Ebola vaccine
Coverage of Ebola vaccine in the Nexus archive.
- Ebola vaccine made in UK now ready for trials
A new Ebola vaccine developed in the UK is now ready for human trials. The vaccine aims to tackle the Ebola virus and will be tested on people.
- UK begins trials of Ebola vaccine developed in just eight weeks
The UK has approved trials of an experimental Ebola vaccine developed in eight weeks, which will be tested on healthy adults.
- UK begins trials of Ebola vaccine developed in just eight weeks
The UK medicines regulator approved trials of an experimental Ebola vaccine for testing on healthy adults. The vaccine was developed in eight weeks, marking a rapid response to the disease.
- Ebola Vaccine Trials Could Start This Year
Ebola vaccine trials could begin this year, as indicated by the article title. The content does not provide additional details.
- UK scientists developing new Ebola vaccine that could be ready in months
UK scientists are developing a new vaccine for the Bundibugyo species of Ebola, which could be ready within months. Bundibugyo is a rare Ebola variant with a fatality rate of approximately one-third of infected individuals and currently has no proven vaccine available.
- UK scientists developing new Ebola vaccine that could be ready in months
UK scientists are developing a new vaccine for Bundibugyo Ebola, a rare species of the virus that kills approximately one-third of infected individuals. The vaccine could be ready within months, addressing a critical gap as no proven vaccine currently exists for this particular Ebola strain.
- Ebola vaccine could take nine months as death toll rises further, WHO warns
The World Health Organization warns that an Ebola vaccine could take nine months to develop as the outbreak continues to spread. The latest update reports 139 suspected deaths and 600 cases, indicating the severity of the crisis.